Federated Hermes, Inc. 13D and 13G filings for Arcturus Therapeutics Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-17 2:43 pm Purchase | 2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 4,711,512 17.630% | 471,958 (+11.13%) | Filing |
| 2023-02-01 10:11 am Purchase | 2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 4,239,554 16.000% | 544,625 (+14.74%) | Filing |
| 2022-02-14 1:07 pm Purchase | 2021-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 3,694,929 14.020% | 242,119 (+7.01%) | Filing |
| 2021-01-08 2:00 pm Purchase | 2020-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT | FEDERATED HERMES INC. FHI | 3,452,810 13.350% | 3,452,810 (New Position) | Filing |